Anebulo Pharmaceuticals, Inc. (ANEB)
Every FINRA and SEC series the site collects for Anebulo Pharmaceuticals, Inc.: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on OTC.
6K
Short interest
settlement 2026-08-31
30.6
Days to cover
+0.0% vs prior
38.7%
Short share of volume
2026-02-27
4,312
Fails to deliver
settlement 2026-03-18
Mon 28 Sep
Next earnings
estimated; last year 2025-09-29
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-08-31.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 31 August 2026, short interest in ANEB is 5,635 shares, unchanged over the last month. Over the last 48 readings it ranged from 2,671 shares (13 December 2024) to 452,993 shares (29 August 2025). The latest reading sits at the bottom of that range. At the reported average volume of 184 shares a day that is 30.6 days to cover, a crowded short.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/aneb" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 5,635 | +0.0% | 184 | 30.63 |
| 2026-08-14 | 5,635 | +0.0% | 540 | 10.44 |
| 2026-07-31 | 5,635 | +0.0% | 907 | 6.21 |
| 2026-07-15 | 5,635 | +0.2% | 644 | 8.75 |
| 2026-06-30 | 5,623 | -0.5% | 2,367 | 2.38 |
| 2026-06-15 | 5,649 | -1.8% | 10,324 | 1.00 |
| 2026-05-29 | 5,752 | +0.0% | 10,074 | 1.00 |
| 2026-05-15 | 5,752 | +0.0% | 4,473 | 1.29 |
| 2026-04-30 | 5,752 | -0.4% | 6,644 | 1.00 |
| 2026-04-15 | 5,777 | -0.0% | 13,303 | 1.00 |
| 2026-03-31 | 5,778 | -90.4% | 57,072 | 1.00 |
| 2026-03-13 | 60,322 | -56.9% | 156,442 | 1.00 |
| 2026-02-27 | 140,018 | -4.3% | 120,215 | 1.16 |
| 2026-02-13 | 146,372 | +188.8% | 124,954 | 1.17 |
| 2026-01-30 | 50,692 | -12.7% | 70,257 | 1.00 |
| 2026-01-15 | 58,049 | -15.5% | 38,100 | 1.52 |
| 2025-12-31 | 68,730 | -41.3% | 196,189 | 1.00 |
| 2025-12-15 | 117,022 | -3.6% | 11,010 | 10.63 |
| 2025-11-28 | 121,417 | +4.1% | 22,049 | 5.51 |
| 2025-11-14 | 116,684 | -28.6% | 19,220 | 6.07 |
| 2025-10-31 | 163,504 | -10.8% | 17,028 | 9.60 |
| 2025-10-15 | 183,314 | -6.8% | 25,040 | 7.32 |
| 2025-09-30 | 196,744 | -51.3% | 68,877 | 2.86 |
| 2025-09-15 | 404,330 | -10.7% | 168,503 | 2.40 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 27 February 2026, the short share of ANEB volume is 38.7%, up 7.0 points over the last five sessions. Over the last 52 readings it ranged from 1.9% (12 December 2025) to 96.4% (26 February 2026). The latest reading is 5.9 points below the 30-session average of 44.6%, on 163K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-02-27 | 63K | 163K | 38.7% | 10,092 |
| 2026-02-26 | 10K | 11K | 96.4% | 0 |
| 2026-02-25 | 11K | 27K | 39.8% | 0 |
| 2026-02-24 | 11K | 39K | 29.6% | 0 |
| 2026-02-23 | 19K | 34K | 54.8% | 0 |
| 2026-02-20 | 23K | 72K | 31.7% | 0 |
| 2026-02-19 | 13K | 24K | 54.4% | 0 |
| 2026-02-18 | 14K | 14K | 96.1% | 0 |
| 2026-02-17 | 3K | 4K | 78.6% | 0 |
| 2026-02-13 | 9K | 17K | 52.6% | 0 |
| 2026-02-12 | 2K | 12K | 17.9% | 0 |
| 2026-02-11 | 6K | 13K | 47.9% | 0 |
| 2026-02-10 | 18K | 24K | 75.0% | 0 |
| 2026-02-09 | 46K | 76K | 60.4% | 7,149 |
| 2026-02-06 | 157K | 287K | 54.7% | 12,032 |
| 2026-02-05 | 9K | 24K | 36.1% | 179 |
| 2026-02-04 | 8K | 22K | 36.1% | 0 |
| 2026-02-03 | 5K | 63K | 8.6% | 309 |
| 2026-02-02 | 23K | 60K | 38.6% | 3,219 |
| 2026-01-30 | 67K | 107K | 62.8% | 1,126 |
| 2026-01-29 | 368 | 4K | 9.9% | 40 |
| 2026-01-28 | 5K | 21K | 23.0% | 14 |
| 2026-01-27 | 12K | 35K | 34.6% | 486 |
| 2026-01-26 | 7K | 15K | 50.5% | 0 |
| 2026-01-23 | 5K | 9K | 55.7% | 0 |
| 2026-01-22 | 2K | 14K | 16.9% | 0 |
| 2026-01-21 | 23K | 56K | 40.2% | 0 |
| 2026-01-20 | 52K | 138K | 37.5% | 0 |
| 2026-01-16 | 10K | 59K | 16.4% | 0 |
| 2026-01-15 | 14K | 32K | 42.4% | 0 |
Fails to deliver
SEC, by settlement date. JSONAs of 18 March 2026, the fails-to-deliver balance in ANEB is 4,312 shares, up 3,208 shares over the last settlement date. Over the last 52 readings it ranged from 15 shares (27 October 2025) to 8,572 shares (26 September 2025).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-03-18 | 4,312 | $0.87 | $4K |
| 2026-03-17 | 1,104 | $0.66 | $729 |
| 2026-03-03 | 1,001 | $0.43 | $430 |
| 2026-03-02 | 1,189 | $0.36 | $428 |
| 2026-02-26 | 15 | $0.43 | $6 |
| 2026-02-13 | 36 | $0.47 | $17 |
| 2026-02-12 | 802 | $0.47 | $377 |
| 2026-02-11 | 6,554 | $0.48 | $3K |
| 2026-02-03 | 96 | $0.96 | $92 |
| 2026-02-02 | 1,421 | $1.05 | $1K |
| 2026-01-29 | 154 | $0.85 | $131 |
| 2026-01-21 | 38 | $1.09 | $41 |
| 2026-01-20 | 718 | $1.09 | $783 |
| 2025-12-30 | 3,292 | $0.99 | $3K |
| 2025-12-24 | 6,487 | $1.19 | $8K |
| 2025-12-22 | 239 | $2.17 | $519 |
| 2025-12-18 | 374 | $2.36 | $883 |
| 2025-12-16 | 566 | $2.17 | $1K |
| 2025-12-11 | 650 | $2.15 | $1K |
| 2025-12-10 | 2,918 | $2.22 | $6K |
| 2025-12-09 | 1,126 | $2.27 | $3K |
| 2025-12-03 | 40 | $2.38 | $95 |
| 2025-12-02 | 55 | $2.36 | $130 |
| 2025-12-01 | 744 | $2.35 | $2K |
| 2025-11-26 | 187 | $2.47 | $462 |
| 2025-11-17 | 49 | $2.28 | $112 |
| 2025-11-14 | 3,375 | $2.41 | $8K |
| 2025-11-13 | 105 | $2.37 | $249 |
| 2025-11-07 | 763 | $2.50 | $2K |
| 2025-11-04 | 252 | $2.54 | $640 |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for ANEB in the last 90 days. The most recent filings are listed below; grants and option exercises carry a weaker signal than voluntary trades. Latest filing: English Aron R. (Director,TenPercentOwner) on 2024-12-23.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2024-12-23 | English Aron R. | Director,TenPercentOwner | Buy | 10.1M | $0.99 | $10.0M | 15.5M |
| 2023-12-18 | 22NW, LP | TenPercentOwner | Gift | 300K | $0.00 | $0 | 0 |
| 2023-11-13 | 22NW, LP | TenPercentOwner | Grant | 300K | $0.00 | $0 | 300K |
| 2022-09-28 | English Aron R. | Director,TenPercentOwner | Grant | 1.7M | $2.81 | $4.8M | 5.1M |
| 2021-12-17 | 22NW Fund, LP | Other | Buy | 400 | $6.59 | $3K | 3.4M |
| 2021-12-14 | 22NW Fund, LP | Other | Buy | 412 | $5.90 | $2K | 3.4M |
| 2021-12-03 | 22NW Fund, LP | Other | Buy | 5K | $5.93 | $27K | 3.4M |
| 2021-12-02 | 22NW Fund, LP | Other | Buy | 14K | $5.30 | $73K | 3.4M |
| 2021-05-06 | 22NW, LP | TenPercentOwnerOther | Grant | 714K | $7.00 | $5.0M | 3.3M |
| 2021-05-06 | 22NW Fund, LP | TenPercentOwnerOther | Grant | 714K | $7.00 | $5.0M | 3.3M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON3 holders above 5% have filed on ANEB, all on Schedule 13G (passive). The largest reported stake is Nantahala Capital Management, LLC at 8.5% of the class (3,547,398 shares), filed 2026-02-13 for an event on 2025-12-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-02-13 | 13G/Ano. 1 | Nantahala Capital Management, LLCinvestment adviser | 3.5M | 8.5% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 1 | Wilmot B. Harkeyparent holding company | 3.5M | 8.5% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 1 | Daniel Mackparent holding company | 3.5M | 8.5% | 2025-12-31 |
What this page is
Anebulo Pharmaceuticals, Inc. in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows Anebulo Pharmaceuticals, Inc. (ANEB), SEC CIK 1815974, listed on OTC. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-02-27.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-03-18.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-02-13.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-02-12.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2024-12-23.JSON and CSV
- Company record
- EDGAR filing index for CIK 1815974Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- TEAMAtlassian Corp
- CVNACARVANA CO.
- CRMSalesforce, Inc.
- METAMeta Platforms, Inc.
- UTHRUNITED THERAPEUTICS Corp
- CRWVCoreWeave, Inc.
- RCGRENN Fund, Inc.
- ANETArista Networks, Inc.
- DDOGDatadog, Inc.
- NETCloudflare, Inc.
- DELLDell Technologies Inc.
- GOOGAlphabet Inc.
- CRWDCrowdStrike Holdings, Inc.
- TPLTexas Pacific Land Corp
- MRNAModerna, Inc.
- COINCoinbase Global, Inc.
- NOWServiceNow, Inc.
- MORNMorningstar, Inc.
- CPIXCUMBERLAND PHARMACEUTICALS INC
- DASHDoorDash, Inc.
- ZMZoom Communications, Inc.
- TDGTransDigm Group INC
- UBERUber Technologies, Inc
- PCTYPaylocity Holding Corp
Datasets
Frequently Asked Questions
How much of ANEB is sold short?
What is ANEB's daily short volume?
Does ANEB have fails to deliver?
Are ANEB insiders buying or selling?
Who owns more than 5% of ANEB?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.